Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69833243 | 6983324 | 3 | F | 20090224 | 20160706 | 20090430 | 20160916 | PER | US-ASTRAZENECA-2009UW05004 | ASTRAZENECA | 20937.00 | DY | F | Y | 64.40000 | KG | 20160916 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69833243 | 6983324 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 80360 | MG | U | U | 21153 | 40 | MG | QD | ||||
| 69833243 | 6983324 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | Y | U | 0 | 5 | MG | TABLET | QD | |||||
| 69833243 | 6983324 | 3 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | Y | U | 0 | 5 | MG | TABLET | QOD | |||||
| 69833243 | 6983324 | 4 | C | VITAMINS | VITAMINS | 1 | 0 | ||||||||||||
| 69833243 | 6983324 | 5 | C | COQ10 | UBIDECARENONE | 1 | Oral | 1 TSP, DAILY | 0 | ||||||||||
| 69833243 | 6983324 | 6 | C | NATURE MADE D3 | 2 | Oral | 1000 UNITS, DAILY | 0 | |||||||||||
| 69833243 | 6983324 | 7 | C | CALTRATE SOFT CHEW WITH D AND CALCIUM | 2 | Oral | DAILY | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 69833243 | 6983324 | 1 | Gastrooesophageal reflux disease |
| 69833243 | 6983324 | 2 | Blood cholesterol increased |
| 69833243 | 6983324 | 3 | Blood cholesterol increased |
| 69833243 | 6983324 | 4 | Supplementation therapy |
| 69833243 | 6983324 | 5 | Muscle spasms |
| 69833243 | 6983324 | 6 | Vitamin D deficiency |
| 69833243 | 6983324 | 7 | Osteoporosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 69833243 | 6983324 | Blood cholesterol increased | |
| 69833243 | 6983324 | Feeling abnormal | |
| 69833243 | 6983324 | Flatulence | |
| 69833243 | 6983324 | Gastric disorder | |
| 69833243 | 6983324 | Intentional product misuse | |
| 69833243 | 6983324 | Limb discomfort | |
| 69833243 | 6983324 | Muscle spasms | |
| 69833243 | 6983324 | Musculoskeletal stiffness | |
| 69833243 | 6983324 | Off label use | |
| 69833243 | 6983324 | Pain in extremity | |
| 69833243 | 6983324 | Product taste abnormal | |
| 69833243 | 6983324 | Throat irritation | |
| 69833243 | 6983324 | Vitamin D deficiency |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 69833243 | 6983324 | 1 | 20090223 | 0 | ||
| 69833243 | 6983324 | 2 | 20140322 | 20141008 | 0 | |
| 69833243 | 6983324 | 3 | 201605 | 0 | ||
| 69833243 | 6983324 | 5 | 2014 | 0 | ||
| 69833243 | 6983324 | 6 | 2014 | 0 |